What is the 13F Pro Quality Score for MTEX?

13F Pro ranks MANNATECH INC (MTEX) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View MTEX's current score at https://13fpro.ai/research/MTEX (free sign-up required for the full ranking).

Where does 13F Pro source MTEX data?

All MANNATECH INC fundamentals and ownership data come directly from SEC EDGAR. MANNATECH INC files with the SEC under CIK 1056358. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is MTEX in?

MANNATECH INC (MTEX) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is MTEX research updated on 13F Pro?

MTEX's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

MANNATECH INC(MTEX)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1056358 MTEX stock profile & AI dashboard →

13F Pro Quality Score

26.8/100

Rank #2,492 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

6.5/100

Profitability

34.4/100

Balance Sheet

25.0/100

Earnings Quality

30.0/100

Free Cash Flow

34.3/100

Institutional Flow

27.6/100

Revenue Scale

19.0/100

Dilution Risk

80.8/100

MTEX Stock Analysis & AI Quality Score

AI stock analysis and institutional research for MANNATECH INC (MTEX), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MTEX at 26.8/100 on a 32-signal composite quality model, placing it at rank #2,492 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (6.5) and revenue scale (19.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2025), MANNATECH INC reports quarterly revenue of $26.6M, net income of $-11.3M, an operating margin of -0.6%. Top institutional holders of MTEX by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. MTEX trades on the Nasdaq exchange and files with the SEC under CIK 1056358. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MTEX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MANNATECH INC directly from SEC EDGAR. MANNATECH INC's 13F Pro composite quality score has ranged between 23 and 48 since 2021, currently 26.8 — a declining long-term trajectory across 28 quarterly and live scoring snapshots.

✦

Fun facts about MANNATECH INC

Quirks, history, and lore behind MTEX — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare company · micro-cap · listed on Nasdaq · headquartered in Texas.
2
The Numbers
Annual revenue in the range of roughly $150–180 million, with a direct-sales network that spans dozens of countries — big footprint, modest bottom line.
3
The History
Founded in the 1990s, the company was built around a proprietary family of glyconutrient supplements — a nutritional science niche it essentially made its own.
4
The Secret
It sells almost exclusively through independent associates — a multi-level marketing structure where your upline makes money when you make sales.
5
The Lore
Its flagship product line is rooted in the science of glycobiology — the study of sugars and their role in cellular communication — a field most supplement brands wouldn't dare touch.
6
The Giveaway
This Texas-based MLM health company built its empire on Ambrotose, a glyconutritional supplement beloved by its distributor army and puzzling to everyone else.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q4 2025

$26.6M

Net Income

Q4 2025

$-11.3M

Free Cash Flow

Q4 2025

$-463.0K

Operating Margin

Q4 2025

-0.6%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-8.3% YoY

$108.0MFY 2025

FY22 $137.2MFY23 $132.0MFY24 $117.9MFY25 $108.0M

Net Income

-708.5% YoY

$-15.2MFY 2025

FY22 $-4.5MFY23 $-2.2MFY24 $2.5MFY25 $-15.2M

Operating Income

-129.8% YoY

$-426.0KFY 2025

FY22 $-405.0KFY23 $-964.0KFY24 $1.4MFY25 $-426.0K

EPS (Diluted)

-706.1% YoY

$-8.00FY 2025

FY22 $-2.35FY23 $-1.20FY24 $1.32FY25 $-8.00

Total Assets

-16.8% YoY

$30.0MFY 2025

FY22 $49.1MFY23 $41.2MFY24 $36.1MFY25 $30.0M

Total Debt

-7.8% YoY

$2.8MFY 2025

FY22 —FY23 —FY24 $3.0MFY25 $2.8M

Op. Cash Flow

-231.0% YoY

$-3.0MFY 2025

FY22 $-2.6MFY23 $-2.4MFY24 $2.3MFY25 $-3.0M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$108.0M -8.3%	$117.9M -10.7%	$132.0M -3.8%	$137.2M -14.1%	$159.8M +5.5%	$151.4M
Net Income	$-15.2M -708.5%	$2.5M +213.6%	$-2.2M +51.0%	$-4.5M -145.6%	$9.8M +57.2%	$6.3M
Operating Income	$-426.0K -129.8%	$1.4M +248.2%	$-964.0K -138.0%	$-405.0K -104.5%	$9.0M +101.5%	$4.5M
EPS (Diluted)	$-8.00 -706.1%	$1.32 +210.0%	$-1.20 +48.9%	$-2.35 -149.9%	$4.71 +70.0%	$2.77
Total Assets	$30.0M -16.8%	$36.1M -12.5%	$41.2M -16.1%	$49.1M -17.6%	$59.6M -8.7%	$65.3M
Total Debt	$2.8M -7.8%	$3.0M	—	—	—	—
Operating Cash Flow	$-3.0M -231.0%	$2.3M +195.4%	$-2.4M +8.8%	$-2.6M -124.1%	$10.8M +78.7%	$6.0M

Get alerted when MTEX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for MANNATECH INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of MTEX

BlackRock, Inc.
$301.5K52,163 sh
VANGUARD CAPITAL MANAGEMENT LLC
$297.7K49,617 sh
RENAISSANCE TECHNOLOGIES LLC
$178.5K30,878 sh
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$173.7K28,954 sh
DIMENSIONAL FUND ADVISORS LP
$71.5K11,925 sh
VANGUARD FIDUCIARY TRUST CO
$16.1K2,679 sh
UBS Group AG
$2.8K485 sh
Tower Research Capital LLC (TRC)
$2.7K472 sh
Vanguard Global Advisers, LLC
$1.5K250 sh
JONES FINANCIAL COMPANIES LLLP
$909.00150 sh

Fund	Value	Shares
BlackRock, Inc.	$301.5K	52,163
VANGUARD CAPITAL MANAGEMENT LLC	$297.7K	49,617
RENAISSANCE TECHNOLOGIES LLC	$178.5K	30,878
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$173.7K	28,954
DIMENSIONAL FUND ADVISORS LP	$71.5K	11,925
VANGUARD FIDUCIARY TRUST CO	$16.1K	2,679
UBS Group AG	$2.8K	485
Tower Research Capital LLC (TRC)	$2.7K	472
Vanguard Global Advisers, LLC	$1.5K	250
JONES FINANCIAL COMPANIES LLLP	$909.00	150

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put MTEX on your watchlist

Track score changes the day MANNATECH INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is MTEX a good stock to buy?

13F Pro's AI-powered analysis of MANNATECH INC (MTEX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MTEX are available on the MTEX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own MTEX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MTEX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MANNATECH INC's investment landscape.